Syschem Share Price Today | Stock Price & Syschem Share Screener
As of October 5, 2026, the live Syschem share price (BSE: SYSCHEM) is ₹34.40, down 1.15% from the previous close, with shares trading between ₹34.05 and ₹35.67 in today's trading session, and a 52-week range of ₹29.40–₹59.66. Check SYSCHEM 52-week performance for the annual price range and momentum. Use the Syschem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Syschem opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹574 and net income of ₹6, with EBITDA of ₹19, an operating margin of 3.0% and a profit margin of 1.1%.
Syschem Share Price Chart
Track the current stock price of Syschem with an interactive chart. Analyse SYSCHEM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Syschem stock quote in one place.
The quote of ₹34.40 sits between the 52-week low of ₹29.40 and the 52-week high of ₹59.66, and the latest session moved -1.15% from the previous close.
Syschem Company Profile - Fundamental Screener
Screen Syschem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SYSCHEM shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE121D01036.
Company Details
Classification
Identifiers and Leadership
Syschem Balance Sheet Screener
Screen SYSCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹292, up from ₹217 in 2025.
Latest statistics put total assets at ₹292 and shareholder funds at ₹122.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 292 | 217 | 164 | 93 | 60 | 77 | 63 | 62 | 58 | 44 |
| Current Assets | 219 | 161 | 126 | 59 | 24 | 42 | 31 | 32 | 26 | 11 |
| Fixed Assets | 68 | 53 | 31 | 31 | 32 | 30 | 28 | 27 | 29 | 29 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 6 | 2 | 10 | 27 | 27 | 29 | 14 | 13 | 14 | 15 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 122 | 91 | 57 | 22 | 7 | 7 | 10 | 12 | 9 | 7 |
| Share Capital | 49 | 44 | 40 | 32 | 23 | 22 | 19 | 19 | 16 | 16 |
| Reserves & Surplus | 73 | 48 | 17 | -10 | -17 | -16 | -10 | -8 | -9 | -9 |
Syschem Income Statement Screener - Profit & Revenue Analysis
Screen Syschem income statement and profit fundamentals. Analyze SYSCHEM quarterly results. Syschem reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹574 and net profit was ₹6, equal to earnings per unit of ₹1.50, at an operating margin of 3%.
In that period expenses were ₹555, interest cost ₹3 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹655 and net profit of ₹11.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||
| Revenue | 574 | 655 | 386 | 234 | 131 | 66 | 75 | 77 | 93 | 67 | 13 | 4 | 11 |
| Expenses | 555 | 634 | 382 | 227 | 122 | 65 | 80 | 77 | 90 | 64 | 13 | 5 | 14 |
Operating Costs and Margins | |||||||||||||
| EBITDA | 19 | 21 | 4 | 7 | 9 | 1 | -5 | 0 | 4 | 3 | 0 | -1 | -3 |
| Operating Profit % | 3.00% | 3.00% | 1.00% | 3.00% | 7.00% | 1.00% | -7.00% | 0.00% | 4.00% | 5.00% | 0.00% | -24.00% | -23.00% |
| Depreciation | 5 | 4 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Profit and Earnings | |||||||||||||
| Profit Before Tax | 12 | 15 | 1 | 4 | 6 | -2 | -7 | -2 | 2 | 1 | -2 | -3 | -5 |
| Tax | 1 | 4 | 1 | 1 | 2 | -1 | -2 | 0 | 1 | 0 | -1 | -1 | -1 |
| Net Profit | 6 | 11 | 1 | 3 | 5 | -2 | -6 | -2 | 1 | 0 | -2 | -2 | -4 |
| EPS | 1.50 | 2.23 | 0.11 | 0.78 | 1.53 | -0.76 | -2.70 | -0.99 | 0.43 | 0.21 | -0.93 | -0.14 | -0.24 |
Syschem Cash Flow Screener - Liquidity Fundamentals
Screen SYSCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹8, and net cash flow was an inflow of ₹6.
Over the same period, investing activities used ₹20 and financing activities provided ₹18.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 8 | -10 | -26 | -9 | 1 | 4 | 4 | -2 | 0 | 6 |
| Investing Activities | -20 | -22 | -7 | -2 | -1 | -4 | -4 | 2 | 0 | 0 |
Financing and Net Cash | ||||||||||
| Financing Activities | 18 | 34 | 32 | 11 | 0 | 0 | 0 | 0 | 0 | -7 |
| Net Cash Flow | 6 | 2 | -1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Syschem Shareholding Pattern Screener
See Syschem shareholding pattern with promoter, FII, and DII holdings. Check Syschem promoter holding and ownership changes for SYSCHEM on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 60.86%, foreign institutions 0.00%, domestic institutions 0.16% and the public 29.94%, spread across 12,901 shareholders.
The shareholder count was 12,901 in 2026-Mar, compared with 12,809 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Jul | 2025-Mar | 2025-Apr | 2025-Jun | 2025-Sept | 2025-Dec |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 60.86% | 60.15% | 63.38% | 57.02% | 57.02% | 56.71% | 56.71% | 56.71% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.16% | 0.16% | 0.15% | 0.18% | 0.18% | 0.18% | 0.18% | 0.18% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 29.94% | 30.08% | 27.85% | 33.37% | 33.37% | 33.46% | 33.10% | 33.01% |
| Other Holding | 9.03% | 9.61% | 8.61% | 9.43% | 9.43% | 9.64% | 10.01% | 10.10% |
| Shareholder Count | 12,901 | 12,809 | 12,825 | 13,223 | 13,223 | 12,906 | 13,273 | 12,836 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Syschem. Syschem dividend yield can be compared with peers and other stocks in the market.
Syschem Stock Index Membership - Nifty & Sensex
See which indices include Syschem stock. Check SYSCHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Syschem Market Events Screener - Corporate Actions
Get Syschem corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Syschem stock events that may affect SYSCHEM share price, along with derivatives, futures and options activity and sector gainers.
13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.
It is followed by Quarterly Result Announcement dated August 4, 2026 and Quarterly Result Announcement dated May 25, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | 17.04% |
| 2026-08-04 | 2026-08-04 | Quarterly Result Announcement | NA | -3.22% |
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 0.22% |
| 2026-02-02 | 2026-02-02 | Quarterly Result Announcement | NA | -4.87% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 7.04% |
| 2025-09-04 | 2025-09-04 | Annual General Meeting | NA | 30.54% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | -4.61% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | -2.72% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -7.35% |
| 2025-01-20 | 2025-01-20 | Extraordinary General Meeting | NA | -7.52% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | 18.48% |
| 2024-08-07 | 2024-08-07 | Annual General Meeting | NA | -4.19% |
| 2023-09-28 | 2023-09-29 | Rights | 1:4 | 4.00% |
Syschem Competitors Screener - Peer Stocks Comparison
Screen SYSCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 427,969 | 35.84 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 243,674 | 84.36 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 180,621 | 84.01 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 113,835 | 24.88 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 108,067 | 32.42 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 105,966 | 98.56 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 102,741 | 50.48 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 100,278 | 31.47 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,313 | 25.97 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 92,121 | 16.71 | 29,039 | 26.75% | 5,356 | 31.59 |
Syschem Company Announcements - News & Reports Screener
Screen SYSCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 2, 2026.
The next most recent announcements are dated October 2, 2026 and September 30, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-02 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-02 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-30 | Announcement Under Regulation 30: Clarification On Price Movement. | - |
| 2026-09-30 | Clarification sought from Syschem India Ltd | - |
| 2026-09-15 | Closure of Trading Window | - |
| 2026-09-04 | Shareholder Meeting/Postal Ballot: Newspaper Advertisements After Dispatch Of Notice To The Shareholders. | - |
| 2026-09-03 | Shareholders Meeting: Notice Of 33Rd Annual General Meeting. | - |
| 2026-09-03 | Reg. 34 (1) Annual Report. | - |
| 2026-09-02 | Newspaper Advertisements As Per Regulation 47 Of SEBI(Listing Obligations And Disclosure Requirements) 2015. | - |
| 2026-09-01 | Announcement Under Regulation 30: Update/Additional Information On The Resignation Of Statutory Auditor Dated 31St August 2026. | - |
| 2026-09-01 | General: Clarification To Board Meeting Dated 01.09.2026 | - |
| 2026-09-01 | Shareholder Meeting/ Postal Ballot : Approval Of Annual General Meeting Date As 30.09.2026. | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-01 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 01.09.2026 | - |
| 2026-08-31 | Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors | - |
| 2026-08-10 | General Update_ Clarification On Investor Presentation | - |
| 2026-08-08 | Investor Presentation | - |
| 2026-08-06 | Newspaper Advertisements | - |
| 2026-08-05 | Clarification In Regards To The Lapse Of Share Warrants Uploaded On 04.08.2026 As Per Regulation 30 Of SEBI(Listing Obligations And Disclosure Requirements) 2015 | - |
| 2026-08-04 | Board Meeting Outcome for Outcome Of Board Meeting | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹34.40, within a 52-week range of ₹29.40 to ₹59.66. The P/E ratio is 30.26 and the P/B ratio is 1.30, with earnings per unit of ₹2.23. Market capitalisation stands at ₹184.72 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.